AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2018

Nov 6, 2018

SEC Form 4/A — Form 4/A

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2018-09-12

Reporting Person: MARAGANORE JOHN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-12	Common stock	S	0	—	Disposed	36209	Direct

Footnotes

F1: On September 13, 2018, the reporting person filed a Form 4 reporting the sale of 14,162 shares of common stock. The previously reported transaction was subsequently broken and unwound by the broker and, therefore, did not in fact occur for the reporting person's account. As of September 12, 2018, the reporting person beneficially owned 36,209 shares of common stock of Agios Pharmaceuticals, Inc.